Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Brain Neoplasms 4Carcinoma, Hepatocellular 2Small Cell Lung Carcinoma 1Motor Activity 1Lung Neoplasms 1Glioblastoma 1Fibrosis 1Epilepsy 1Cognitive Dysfunction 1Breast Neoplasms 1Breast Cancer Early Stage Breast Cancer (Stage 1-3) 1

Interventions

Sirolimus 2Therapeutic Touch 1Temozolomide 1Sulfasalazine 1Radiotherapy 1Memantine 1Medical Marijuana 1Magnetoencephalography 1Gabapentin 1Clinical Laboratory Techniques 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Epilepsy × Memantine × Clear all
NCT05664464 2024-05-10

GLUGLIO

University of Zurich

Phase 1/2 Recruiting
120 enrolled
CNS

Epilepsy, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡